{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "RGTI",
  "name": "Rigetti Computing, Inc.",
  "url": "https://orbyd.app/dossiers/RGTI/",
  "json_url": "https://orbyd.app/dossiers/RGTI.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a6",
    "n": 6
  },
  "current_thesis": "Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the Quantinuum IPO landing into the tape mark late-cycle supply. No company binary until the Q2 print ~2026-08-10. Avoid fresh entries.",
  "invalidation_trigger": "A weekly close below $12.53 takes out the 52-week low and confirms the quantum pure-play theme has gone from saturated to dead, with no bid until a company-specific contract event; corroborating tells would be an ATM-issuance 8-K filed into any bounce, or the ~2026-08-10 Q2 print passing without a named Fortune-500 Cepheus customer.",
  "catalyst_date": "2026-08-06",
  "outcome": "INVALIDATED",
  "outcome_date": "2026-06-24",
  "invalidation_fired": true,
  "themes": [
    "quantum-computing"
  ],
  "tags": [
    "watchlist"
  ],
  "sources": [],
  "notes": [
    "2026-04-18: seed: Serenity/attention list",
    "Rigetti funds itself through a standing at-the-market equity program; 332.40M shares were outstanding at 2026-07-31, up 47.61% year over year.",
    "The up-to-$100M Commerce award is a non-binding letter of intent. Its equity component prices at a 15% discount to the lowest of three closes, so weakness enlarges the government stake.",
    "Short interest is 61.35M shares, 18.72% of float, at 2.17 days to cover. Single headlines routinely produce 7-9% sessions in this name.",
    "Leveraged 2X long and 2X inverse single-stock ETFs on the quantum group, including RGTZ, are live and amplify intraday moves in both directions.",
    "Trailing-twelve-month revenue is $10.02M against a $5.80B market cap; one system delivery can swing the reported growth rate by triple digits.",
    "Cepheus-1-108Q runs 99.1% median two-qubit gate fidelity against a ~99.5% target for 2026; the 336-qubit Lyra is guided to late 2026 at 99.7%."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg on offer has not changed: sovereign and national-lab procurement of superconducting quantum hardware from the only US-listed pure-play carrying a federal funding letter, an Indian government system order and an NSF-funded slot inside an HPE machine. What changed since the last update is the tape into the print. RGTI closed $17.45 on 2026-08-04, up 8.93% on 24.19M shares against a $16.02 previous close, in a $16.48–$17.72 range — the third straight advance from $14.95 on 2026-07-31. Market capitalisation is $5.80B against $10.02M of trailing-twelve-month revenue.\n\nRigetti disclosed nothing across those three sessions. Benzinga attributed the 2026-08-04 move to Wedbush assuming coverage at Outperform with a $40 target on 2026-08-03, IBM CEO Arvind Krishna's same-day remark that quantum becomes a meaningful business by 2028, and a 2.88% Nasdaq session. The last company release of substance was TangleLab on 2026-07-27.\n\nThe reclaim repaired part of the short-term structure and none of the long. Price is back above the 20-day simple moving average of $15.29 and remains below the 50-day at $19.05 and the 200-day at $21.57; RSI is 55.12; the death cross formed in February is intact; the 52-week range stands at $12.53–$58.15. Everything company-specific now resolves on 2026-08-06 after the close.\n\n## Bull Case\n\n- **Wedbush, 2026-08-03, Outperform, $40**: models roughly $30.5M of FY2026 revenue against $7.1M reported for FY2025, with $14.8M in Q4 2026 alone, and puts the 2026 test on fidelity progress toward 99.5% rather than qubit count. Benchmark initiated Buy with a $25 target on 2026-07-27. Street average target is $32.00 across 12 analysts at a Moderate Buy consensus (MarketBeat, 2026-08-04).\n- **Financing pressure is not near-term**: $569M of cash, equivalents and saleable investments with no debt at 2026-03-31, against Q1 2026 operating expenses of $27.3M and a $20.5M net loss.\n- **Q2 prints a triple-digit growth rate on a small base**: consensus clusters in a $4.91–5.13M band (Zacks $4.91M; TipRanks ~$5.08M, +182% YoY) with -$0.05 EPS. Q1 2026 revenue was $4.4M, +198.9% YoY, reported 2026-05-11, with management guiding remaining Novera order revenue to book largely in Q2.\n- **TangleLab, announced 2026-07-27**: a 9-qubit Novera QPU integrated with HPE compute, storage and networking at the Pittsburgh Supercomputing Center under a $5M NSF grant; construction starts 2026-09-01, full operation 2027. The dollar value is trivial; the placement inside a national cyberinfrastructure prototype is the point.\n- **C-DAC India, $8.4M, announced 2026-02-26**: a 108-qubit Cepheus-1-108Q for India's Centre for Development of Advanced Computing, delivery slated H2 2026, establishing a per-system price point for the sovereign leg.\n- **Third-party modality validation, 2026-07-30**: IBM and Algorithmiq published a quantum-advantage demonstration on superconducting hardware for heterogeneous-material simulation. Rigetti builds superconducting chiplet processors, so the physics read-through is direct even though the credential belongs to IBM.\n- **Squeeze fuel is loaded**: 61.35M shares short, 18.72% of float, 2.17 days to cover at the latest settlement, up from 50.40M shares and 15.16% one settlement earlier. The short base grew into the July low instead of covering into it.\n\n## Bear Case\n\n- **Valuation carries no cushion**: Motley Fool put price-to-sales at 445 on 2026-07-27 against the Nasdaq-100's 6.1, measured at a then-$4.7B market cap. Capitalisation is $5.80B as of 2026-08-04 on $10.02M of trailing revenue.\n- **The advance had no company input**: $14.95 on 2026-07-31 to $17.45 on 2026-08-04 on two analyst notes and an IBM soundbite. The 2026-08-03 session moved with the whole cohort — D-Wave gapped that morning on its own Nasdaq Verafin proof-of-concept announcement.\n- **Fidelity still short of target**: Cepheus-1-108Q runs 99.1% median two-qubit gate fidelity, roughly nine errors per 1,000 operations, against a ~99.5% goal for 2026; the 336-qubit Lyra is guided to late 2026 at 99.7%. The 84-qubit Ankaa-3 already demonstrated 99.5%, so the 108-qubit step gave back fidelity to gain scale.\n- **Dilution is structural**: 332.40M shares outstanding at 2026-07-31, up 47.61% year over year, funded through a standing at-the-market equity program.\n- **Insider flow runs one direction**: $80.4M of net insider selling at Rigetti since mid-July 2021, part of $988M across IonQ, Rigetti and D-Wave, with negligible offsetting purchases (Motley Fool Form 4 analysis, 2026-07-22).\n- **Federal money is still a letter**: the up-to-$100M Commerce award remains a non-binding letter of intent, unsigned when Commerce announced $874M of CHIPS awards on 2026-07-31 led by GlobalFoundries with no quantum pure-play included.\n- **Retail-facing coverage has turned two-sided**: Cramer said on 2026-07-30 he does not care for the name; a 2026-07-27 Motley Fool piece predicted the stock plummets after 2026-08-06; inverse single-stock quantum ETFs, including RGTZ, printed gains up to 108% on the July drawdown (2026-07-17).\n\n## Setup & Price Structure\n\nWhere the narrative sits in its life-cycle: **SATURATED**. What dates it — retail-facing coverage now cycles on the same name almost daily (Benzinga \"why is it surging\" pieces on 2026-07-21, 2026-07-27 and 2026-08-04; Cramer's lightning round 2026-07-30; Barron's late-July \"tipping point\" framing projecting ~$1.5B of 2026 industry revenue), leveraged 2x long and 2x inverse single-stock ETFs exist on the group, and the July drawdown was deep enough to lift inverse products up to 108% (2026-07-17). The bid that produced 2026-08-03 and 2026-08-04 came from initiations and sector commentary while the company stayed silent.\n\nStructure as of the 2026-08-04 close at $17.45: above the 20-day ($15.29), below the 50-day ($19.05) and the 200-day ($21.57), February's death cross unbroken, RSI 55.12, beta 2.02, 20-day average volume 21.5M shares against 24.19M traded that session. Benzinga marks resistance at $20.50 near the 50-day and support at $15.00 near the 20-day. The $12.53 52-week low printed in July is the structural floor; the 52-week high of $58.15 dates to 2025-10-14.\n\nCrowding and positioning, stated as observables rather than verdicts: price sits roughly two dollars above a 20-day average it only reclaimed this week; the earnings date is one session away; options price a ~13.4% move with implied volatility at 101.65% against 86.76% historic; short interest is 18.72% of float at 2.17 days to cover; share count is up 47.61% year over year through a standing equity program; insider net selling totals $80.4M since mid-July 2021.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-08-31 (est.)** — definitive CHIPS agreement between Rigetti's subsidiary and the Department of Commerce, still unsigned as of 2026-07-31.\n- **2026-09-01** — TangleLab construction start at the Pittsburgh Supercomputing Center, the next dated company execution milestone after the print.\n\n## Elapsed catalysts\n\n- **2026-08-05** — IonQ Q2 2026 results, after close, call 4:30 p.m. ET. Consensus ~$66.58M revenue (+~222% YoY) and -$0.54 EPS against company guidance of $65–68M; options imply 19.55% versus a 9.86% average move over the prior four quarters. IonQ closed its $1.8B SkyWater Technology acquisition on 2026-07-31. *(passed 4d ago)*\n- **2026-08-06** — Rigetti Q2 2026 results, after close, conference call 5:00 p.m. ET (date confirmed 2026-07-24). *(passed 3d ago)*\n- **2026-08-06** — D-Wave Q2 2026 results, call 8:00 a.m. ET. Consensus $4.02M revenue (+30% YoY), -$0.09 EPS, implied move ~13.5%. *(passed 3d ago)*\n\n## What Would Change Our Mind\n\nThe entire 2026-08-03/08-04 advance rests on external inputs, so the first thing that breaks the frame is the market taking it back. A daily close below $14.95 puts price beneath the launch point of the pre-print run and re-exposes the $12.53 52-week low set in July, at which point the theme has moved from saturated to finished and no bid exists until a company-specific contract event.\n\nThe second break is the catalyst arriving empty. If the 2026-08-06 call lands revenue inside the $4.91–5.13M band, reiterates 99.1% median two-qubit gate fidelity with no movement toward 99.5%, names no enterprise Cepheus customer and leaves the Commerce letter of intent unsigned, the binary has resolved to nothing and the next dated company event is a construction start on 2026-09-01. A 2026-08-07 session moving less than 5% with the shares lower would show implied-volatility deflation doing the work on its own.\n\nWhat would argue the other way, with the same specificity: a named sovereign or Fortune-500 Cepheus order disclosed on or after 2026-08-06; a signed definitive Commerce agreement converting the up-to-$100M letter into cash; median two-qubit gate fidelity reported above 99.1% with the 99.5% target reaffirmed for 2026; and a close back above the $19.05 50-day, which would be the first reclaim of that average since February. An at-the-market or follow-on 8-K filed into post-print strength would undercut all of it.\n\n## Correlation Notes\n\n- **The cohort trades as one book.** On 2026-08-03 D-Wave gapped on its Nasdaq Verafin proof-of-concept and RGTI closed +7.16%; on 2026-07-27 the group moved together on D-Wave's AT&T agreement, with IonQ +7.8%. IonQ's 2026-08-05 print lands one session ahead of Rigetti's and sets the tone into it.\n- **Beta 2.02 to the index.** The 2026-08-04 advance coincided with a 2.88% Nasdaq day and a 4.64% move in the broad tech complex; the name does not decouple from risk appetite.\n- **Leveraged single-stock ETFs sit on both sides.** 2x long and 2x inverse products on the quantum names, including RGTZ, rebalance daily and amplify intraday moves in either direction.\n- **Policy headlines are a shared factor.** The May CHIPS-equity story, June's executive orders and the 2026-07-31 $874M CHIPS announcement moved the group as a bloc, independent of any company's revenue line.\n- **IBM and Google research cuts both ways.** The 2026-07-30 IBM/Algorithmiq demonstration validates the superconducting modality Rigetti builds on while crediting an incumbent with the commercial proof point; Krishna's 2026-08-03 \"meaningful by 2028\" framing lifted the pure-plays on the same logic.",
  "first_seen": "2026-04-19",
  "last_analyzed": "2026-08-05T06:03:43+00:00",
  "last_synthesized": "2026-08-05",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}